Private equity investor Advent International, on Tuesday announced the launch of Cohance Lifesciences, a new brand identity for its API (active pharmaceutical ingredient) and CDMO (contract development and manufacturing company) platform. Cohance Lifesciences would help in establishing a unified new brand identity for the API and CDMO platform to better reflect its vision and operating…
Private equity investor Advent International, on Tuesday announced the launch of Cohance Lifesciences, a new brand identity for its API (active pharmaceutical ingredient) and CDMO (contract development and manufacturing company) platform. Cohance Lifesciences would help in establishing a unified new brand identity for the API and CDMO platform to better reflect its vision and operating…
Cohance Lifesciences intends to add more assets in future, to become one of the top three API and CDMO companies in India Private equity firm, Advent International has launched Cohance Lifesciences to hold its active pharmaceutical ingredients (API) business and contract development and manufacturing organisation (CDMO). Cohance will comprise three formerly acquired companies, RA Chem…